Top Abstract Purchase Related
Home
>
Node
>
Subnode

Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver

Gachályi, B.; Vas, A.; Káldor, A.

International Journal of Clinical Pharmacology Therapy and Toxicology 22(7): 353-354

1984

ISSN/ISBN: 0174-4879
PMID: 6469424
Document Number: 227640
Results of animal experiments indicate that indomethacin has a marked inhibitory effect on the activity of the hepatic microsomal mixed function monooxygenase (MFO) enzyme system. In order to verify this effect of indomethacin in humans, the authors studied antipyrine kinetics and D-glucaric acid excretion in 14 patients before and after 7 days treatment with two different doses of the drug. In contrast to the results obtained from animal experiments, there was no change in the activity of MFO in man. This can possibly be explained by species difference.

Document emailed within 1 workday
Secure & encrypted payments

Palut, D.; Kostka, G.; Wiadrowska, B.; Bańkowski, R. 2002: Effect of diclofop on the activity of some drug-metabolizing enzymes in the liver of male Wistar rats Roczniki Panstwowego Zakladu Higieny 53(1): 1-9
Allain, P.; Premel-Cabic, A. 1977: Influence of metals and non-steroid anti-inflammatory drugs on the activity of human red cell ALA dehydratase "in vitro" Pathologie-Biologie 25(8): 535-540
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Chieli, T.; Fregnan, G.B.; Frigerio, L.; Vidali, M. 1976: Toxicity and collateral pharmacological effects of a 3: a new non-steroid anti-inflammatory agent Bollettino Chimico Farmaceutico 115(1): 41-57
Endo, Y.; Tsuriya, S.; Fujihira, E. 1981: Hepatic drug-metabolizing enzyme activities and anti-inflammatory potency of hydrocortisone in rats with granulomatous inflammation Research Communications in Chemical Pathology and Pharmacology 33(2): 195-206
Yamada, Y.; Nakahara, M.; Kohno, M.; Otsuka, M.; Takaiti, O. 1989: Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats Arzneimittel-Forschung 39(3): 356-360
Kurucz, I.; Németh, K.; Mészáros, S.; Török, K.; Nagy, Z.; Zubovics, Z.; Horváth, K.; Bodor, N. 2004: Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid Die Pharmazie 59(5): 412-416
Abe, T. 1994: Steroid and non-steroidal anti-inflammatory drug therapy of vasculitis Nihon Rinsho. Japanese Journal of Clinical Medicine 52(8): 2173-2176
Kurata, N.; Yoshida, T.; Kuroiwa, Y.; Masuko, T.; Hashimoto, Y. 1989: Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme Research Communications in Chemical Pathology and Pharmacology 65(2): 161-179
Accardo, S.; Traverso, A.; Caraffa, M.; Ferretti, A.; Moreno, M. 1978: Use of a new non-steroid, anti-inflammatory drug, ketoprofen, in the therapy of rheumatic diseases Minerva Medica 69(51): 3523-3530
Galtier, P.; Larrieu, G.; Tufenkji, A.E.; Franc, M. 1986: Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(1): 137-141
Kawai, K.; Shiojiri, H.; Fukushima, H.; Nozawa, Y.; Hasegawa, J.; Nozaki, M.; Tsurumi, K.; Fujimura, H. 1984: The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers Research Communications in Chemical Pathology and Pharmacology 45(3): 399-406
Soyka, L.F.; Hunt, W.G.; Knight, S.E.; Foster, R.S. 1976: Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum Cancer Research 36(12): 4425-4428
Marino, L.; Baroni, G.; Riccardi, A.; Franchi, M. 1982: Controlled trial of a prostaglandin-inhibiting, non-steroid, anti-inflammatory drug in primary dysmenorrhea Minerva Ginecologica 34(10): 791-796
Patanè, R.; Bottaro, G.; Ricca, O.; Iudica, M.L.; Costanzo, I.; Cutuli, M. 1985: Acute ulcer of the stomach caused by the concurrent administration of the antipyretic-intended betamethasone and a non-steroid anti-inflammatory drug La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 7(2): 315-317
Sushko, L.I.; Lukienko, P.I. 1979: Effect of thiamine on the activity of liver endoplasmic reticulum enzymes metabolizing drugs Farmakologiia i Toksikologiia 42(1): 56-59
Pachecka, J.; Kobylińska, K.; Suchocka, Z.; Kuczyńska, J. 1993: The effect of short-term alloxan-induced diabetes on the activity of drug metabolizing enzymes Acta Poloniae Pharmaceutica 50(6): 435-439
Mokhort, N.A. 1971: Effect of non-steroid anti-inflammatory agents on proliferative processes in the inflammation focus Farmakologiia i Toksikologiia 34(3): 297-300
Ammar, N.; Gaafar, S.; Khalil, R. 1992: Anti-inflammatory effect of natural steroid sapogenins on oral aphthous ulcers Egyptian Dental Journal 38(1): 89-98